Literature DB >> 12084457

Self-association and unique DNA binding properties of the anti-cancer agent TAS-103, a dual inhibitor of topoisomerases I and II.

Keisuke Ishida1, Tetsuji Asao.   

Abstract

The objective of our study was to investigate the self-association and DNA-binding properties of the DNA topoisomerases I (Topo I) and II (Topo II) dual inhibitor: 6-[[2-(dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinoline-7-one dihydrochloride (TAS-103), by means of 1H-NMR and 31P-NMR spectroscopy, structure computation techniques, thermal melting study, and UV-Visible spectroscopy. In aqueous solution, all chemical shifts of TAS-103 underwent upfield shifts depending with an increase in concentration. The two-dimensional (2D)-NMR spectra and structure computations indicated that TAS-103 self-associated through pi-pi stacking and hydrophobic interactions of the aromatic chromophores. Thermal melting indicated that the binding of TAS-103 to DNA with a potency equal to that of ethidium bromide (EtBr). The UV-Visible spectra of TAS-103 titrated by several DNA exhibited hypochromic and hypsochromic effects. The 31P-NMR spectrum of the 6:1 TAS-103/d(CGCGAATTCGCG)(2) complex showed two broadening signals. 2D-NMR spectra of the 1:1 TAS-103/d(CGCGAATTCGCG)(2) complex indicated that the chemical shift differences of the DNA are very small. However, those of the terminal region are relatively large. The chemical shift differences of TAS-103 showed that the proton resonances except H2 underwent downfield shifts. From these observations, we conclude that TAS-103 binds to DNA by two modes. The major binding mode is on the surface (outside binding) and the minor binding mode by intercalation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084457     DOI: 10.1016/s0925-4439(02)00078-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.

Authors:  Chih-Hua Tseng; Cherng-Chyi Tzeng; Chiao-Li Yang; Pei-Jung Lu; Yu-Peng Liu; Hui-Ling Chen; Chien-Yu Chen; Chia-Ning Yang; Yeh-Long Chen
Journal:  Mol Divers       Date:  2013-11       Impact factor: 2.943

2.  2-Ethyl-6-(2-pyrid-yl)-5,6,6a,11b-tetra-hydro-7H-indeno[2,1-c]quinoline.

Authors:  Arnold R Romero Bohórquez; Vladimir V Kouznetsov; Teresa González; Alexander Briceño
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.